Aggressiveness of therapy and prognosis of patients with Hürthle cell papillary thyroid carcinoma

Thyroid

Volumn 16, Issue 1, 2006, Pages 67-72

  Hocevar, M ^a   Zgajnar, J ^a   Petric, R ^a   Pilko, G ^a   Besic, Nikola ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE INTERVAL; FEMALE; FOLLOW UP; GENDER; HISTOPATHOLOGY; HUMAN; LOG RANK TEST; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SLOVENIA; SUBTOTAL THYROIDECTOMY; SURVIVAL RATE; SURVIVAL TIME; THYROID PAPILLARY CARCINOMA; THYROID PARAFOLLICULAR CELL; THYROIDECTOMY;

ADENOMA, OXYPHILIC; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, PAPILLARY; CELL NUCLEUS; CHILD; COMBINED MODALITY THERAPY; CYTOPLASM; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IODINE; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; SLOVENIA; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 33644761862     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.16.67     Document Type: Article

References (22)

1. Simpson WJ, McKinney SE, Carruthers JS, Gospodarowicz MK, Sutcliffe SB, Panzarella T 1987 Papillary and follicular thyroid cancer. Prognostic factors in 1,578 patients. Am J Med 83:479-488.
2. Berho M, Suster S 1997 The oncocytic variant of papillary carcinoma of the thyroid: A clinicopathologic study of 15 cases. Hum Pathol 28:47-53.
3. Nesland JM, Sobrinho-Simoes MA, Holm R, Sambade MC, Johannessen JV 1985 Hürthle cell lesions of the thyroid: a combined study using transmission electron microscopy, scanning electron microscopy, and immunocytochemistry. Ultrastruct Pathol 8:269-290.
4. Hill JH, Werkhaven JA, DeMay RM 1988 Hürthle cell variant of papillary carcinoma of the thyroid gland. Otolaryngol Head Neck Surg 98:338-341.
5. Beckner ME, Heffess CS, Oertel JE 1995 Oxyphilic papillary thyroid carcinomas. Am J Clin Pathol 103:280-287.
6. Moreira AL, Waisman J, Cangiarella JF 2004 Aspiration cytology of the oncocytic variant of papillary adenocarcinoma of the thyroid gland. Acta Cytol 48:137-141.
7. Rosai J 1992 Tumors with oncocytic features (Hürthle cell tumors). In Rosai J, Carcangiu ML, Delellis RA (eds) Atlas of Tumor Pathology. Armed Forces Institute of Pathology, Washington, pp. 161-182.
8. Herrera MF, Hay ID, Wu PS, Goellner JR, Ryan JJ, Ebersold JR, Bergstralh EJ, Grant CS 1992 Hürthle cell (oxyphilic) papillary thyroid carcinoma: A variant with more aggressive biologic behavior. World J Surg 16:669-674.
9. Besic N, Vidergar-Kralj B, Frkovic-Grazio S, Movrin-Stanovnik T, Auersperg M 2003 The role of radioactive iodine in the treatment of Hürthle cell carcinoma of the thyroid. Thyroid 13:577-584.
10. Hermanek P, Sobin LH 1997 Thyroid gland In: Sobin LH, Wittekind Ch (eds) TNM Classification of Malignant Tumors, 5th ed. John Wiley, New York, pp. 35-37.
11. Sobin LH, Wittekind Ch 2002 Thyroid gland In: Sobin LH, Wittekind Ch (eds) TNM Classification of Malignant Tumours, 6th ed. Wiley-Liss, New York, pp. 52-56.
12. Kaplan EL, Meier P 1985 Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481.
13. Mantel N 1966 Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170.
14. Hay ID, Grant CS, Taylor WF, McConahey WM 1987 Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102:1088-1095.
15. Hedinger C, Williams ED, Sobin LH 1989. The WHO histological classification of thyroid tumors: A commentary on the second edition. Cancer 63:908-911.
16. Oertel JE, LiVolsi VA 1991 Pathology of thyroid diseases. In Braverman LE, Utiger RD (eds) Werner and Ingbar's The Thyroid. A Fundamental and Clinical Text, 6th ed. Lippincott, Philadelphia, pp. 603-642.
17. Gomez Segovia I, Gallowitsch HJ, Kresnik E, Kumnig G, Igerc I, Matschnig S, Stronegger WJ, Lind P 2004 Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984-2001. Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: Population-based age-stratified analysis on thyroid carcinoma incidence. Thyroid 14:277-286.
18. McDonald MP, Sanders LE, Silverman ML, Chan HS, Buyske J 1996 Hürthle cell carcinoma of the thyroid gland: Prognostic factors and results of surgical treatment. Surgery 120:1000-1004.
19. Delbridge L 1992 Invited commentary. World J Surg 16:774-775.
20. Kebebew E, Clark OH 2003 Locally advanced differentiated thyroid cancer. Surg Oncol 12:91-99.
21. Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, Ito K, Takami H, Takanashi Y 2003 Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237:399-407.
22. Besic N, Auersperg M, Us-Krasovec M, Golouh R, Frkovic-Grazio S, Vodnik A 2001 Effect of primary treatment on survival in anaplastic thyroid carcinoma. Eur J Surg Oncol 27:260-264.